| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |